Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence

Although anticoagulation therapy has evolved from non-specific drugs (i.e., heparins and vitamin K antagonists) to agents that directly target specific coagulation factors (i.e., direct oral anticoagulants, argatroban, fondaparinux), thrombosis remains a leading cause of death worldwide. Direct oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Nopp, Stephan, Kraemmer, Daniel, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133368/
https://www.ncbi.nlm.nih.gov/pubmed/35647061
http://dx.doi.org/10.3389/fcvm.2022.903029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133368/
https://www.ncbi.nlm.nih.gov/pubmed/35647061
http://dx.doi.org/10.3389/fcvm.2022.903029

Ejemplares similares